EURURO Vol. 72 No. 4
|
Platinum Opinions |
27 |
|
Immune Checkpoint Inhibition in Metastatic Urothelial Cancer |
27 |
|
If You Want to Make an Important Discovery, Listen to Your Patients |
32 |
|
Platinum Priorities |
33 |
|
Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder |
33 |
|
Brief Correspondence |
38 |
|
Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? |
38 |
|
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories |
42 |
|
Intraductal Carcinoma of the Prostate: Anonymous to Ominous |
46 |
|
Prostate Cancer |
49 |
|
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition |
49 |
|
Adjunct Screening of NKX3.1 Expression Supports 5α-Reductase Inhibition Intervention in Prostate Cancer Active Surveillance |
57 |
|
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology |
59 |
|
Prediction is “Still” Difficult when it is About the Past |
69 |
|
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology |
71 |
|
Prostate Cancer Management in an Ageing Population |
82 |
|
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer |
84 |
|
Active Surveillance: A Ten-year Journey |
92 |
|
Urothelial Cancer |
94 |
|
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy |
94 |
|
Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal? |
105 |
|
Kidney Cancer |
107 |
|
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma |
107 |
|
Applying Precision Oncology to Renal Cell Carcinoma: Emerging Challenges |
115 |
|
Female Urology – Incontinence |
117 |
|
Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence |
117 |
|
Surgical Treatment of Female Stress Urinary Incontinence: Do Tapes Stand the Test of Time? |
142 |
|
Reconstructive Urology |
144 |
|
Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies |
144 |
|
Tissue Engineering of the Urethra: Solid Basic Research and Farsighted Planning are Required for Clinical Application |
157 |
|
Surgery in Motion |
160 |
|
Ureteroscopy-assisted Percutaneous Kidney Access Made Easy: First Clinical Experience with a Novel Navigation System Using Electromagnetic Guidance (IDEAL Stage 1) |
160 |
|
Original Articles |
167 |
|
Prostate Cancer |
167 |
|
Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 Trial |
167 |
|
The Microbiome of the Prostate Tumor Microenvironment |
175 |
|
Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer |
182 |
|
Urothelial Cancer |
191 |
|
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma |
191 |
|
Words of Wisdom |
200 |
|
Re: Inhibition of Cholinergic Neurotransmission by β₃-adrenoceptors Depends on Adenosine Release and A₁ Receptors Activation in Human and Rat Urinary Bladders |
200 |
|
Re: Women with Symptoms of a Urinary Tract Infection but a Negative Urine Culture: PCR-based Quantification of Escherichia coli Suggests Infection in Most Cases |
201 |
|
Re: Treatment Duration of Febrile Urinary Tract Infection: A Pragmatic Randomized, Double-blind, Placebo-controlled Non-inferiority Trial in Men and Women |
202 |
|
Re: The Economic Implications of a Reusable Flexible Digital Ureteroscope: A Cost-Benefit Analysis |
202 |
|
Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma |
203 |
|
Re: The Prostate Health Index Adds Predictive Value to Multi-parametric MRI in Detecting Significant Prostate Cancers in a Repeat Biopsy Population |
204 |
|
Letters to the Editor published online |
207 |
|
Congress Calendar |
222 |